[Diagnostic and therapeutic strategies in hepatocellular XXXX ].

@entity1 @entity548 @entity2695 @entity5 @entity96 @entity397 @entity4383 @entity157 @entity652
While liver @entity2695 and @entity4383 are not considered an indication for surgery in asymptomatic @entity1 resection has been recommended for hepatocellular @entity652 because of the risk of @entity397 and malignant transformation. Problems arise from differential diagnosis and the appropriate surgical radicality including the indication for liver transplantation. This retrospective analysis deals with 58 @entity1 who underwent surgery for hepatocellular @entity652 : resection of different extension: n = 54, liver transplantation n = 4. In 39.6% of the @entity1 the @entity5 was an incidental finding. In 62.0% of the character of the lesion was unclear prior to surgery. @entity5 and @entity548 occurred in 17.2%, malignant transformation in 6.9%. Surgical morbidity was 27.6%, mortality 5.2% with the transplant @entity1 alive for 1.5, 7, 9 and 10 years. Two and five years after resection 2 @entity1 developed @entity157 in the liver remnant. The results confirm the indication for surgery in hepatocellular @entity652 . Diagnostic approach for solid @entity96 without serum increase of @entity5 markers should rule out FNH and @entity2695 . In all other @entity1 surgery should be considered whenever possible with the radicality of @entity5 . Liver transplantation can be discussed even in asymptomatic @entity1 with multiple @entity652 .
